LOXO-260

Eli Lilly axes next-generation, resistance-busting RET inhibitor
Fierce Biotech
Tue, 02/6/24 - 10:14 am
Eli Lilly
LOXO-260
RET inhibitors
thyroid cancer
non-small cell lung cancer